Coronary artery disease (CAD) is the number one cause of death globally, and numbers are rising.1 Healthcare providers need holistic solutions to help them improve diagnostic accuracy, enable effective risk stratification and triage, and support image-guided minimally invasive therapies. Siemens Healthineers has a comprehensive array of multimodality technologies, cardiac biomarkers, a connected digital strategy, and the market foresight to bring cardiology into the future. The unique strengths of our holistic coronary artery disease portfolio help care providers make confident diagnostic decisions on coronary artery disease and get patients on the right pathway – fast. Our clear roadmap is designed to transform care delivery for patients with coronary artery disease.
The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.
The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.
3) See, for example, Zimmermann FM, Omerovic E, Fournier S, et al. Fractional flow reserveguided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data. Eur Heart J 2019; 40(2): 180–86.